Rosenblatt acts for the shareholders of Spanish company Silhouette Lift S.L. in relation to the pre-sale global reorganisation of the business of Silhouette and sale of shares in Silhouette to AIM listed Sinclair IS Pharma plc. The consideration comprised an upfront cash payment of £14.4 million and milestone and royalty payments of up to £55 million. Silhouette is the provider of the ‘one stitch face lift’ products ‘Silhouette Lift’ and ‘Silhouette Soft’. The Rosenblatt team was led by Tom Ferns, Head of Corporate and Gerard Dempsey, Corporate Associate.